Structure-activity relationships of quinoxaline-based 5-HT3A and 5-HT3AB receptor-selective ligands

A.J. Thompson, M.H.P. Verheij, Jacqueline E. van Muijlwijk-Koezen, Sarah C R Lummis, R. Leurs, Iwan de Esch

Research output: Contribution to JournalArticleAcademicpeer-review

Abstract

Until recently, discriminating between homomeric 5‐HT3A and heteromeric 5‐HT3AB receptors was only possible with ligands that bind in the receptor pore. This study describes the first series of ligands that can discriminate between these receptor types at the level of the orthosteric binding site. During a recent fragment screen, 2‐chloro‐3‐(4‐methylpiperazin‐1‐yl)quinoxaline (VUF10166) was identified as a ligand that displays an 83‐fold difference in [3H]granisetron binding affinity between 5‐HT3A and 5‐HT3AB receptors. Fragment hit exploration, initiated from VUF10166 and 3‐(4‐methylpiperazin‐1‐yl)quinoxalin‐2‐ol, resulted in a series of compounds with higher affinity at either 5‐HT3A or 5‐HT3AB receptors. These ligands reveal that a single atom is sufficient to change the selectivity profile of a compound. At the extremes of the new compounds were 2‐amino‐3‐(4‐methylpiperazin‐1‐yl)quinoxaline, which showed 11‐fold selectivity for the 5‐HT3A receptor, and 2‐(4‐methylpiperazin‐1‐yl)quinoxaline, which showed an 8.3‐fold selectivity for the 5‐HT3AB receptor. These compounds represent novel molecular tools for studying 5‐HT3 receptor subtypes and could help elucidate their physiological roles.
Original languageEnglish
Pages (from-to)946-955
Number of pages10
JournalChemMedChem
Volume8
Issue number6
Early online date2 May 2013
DOIs
Publication statusPublished - Jun 2013

Fingerprint

Quinoxalines
Structure-Activity Relationship
Ligands
Granisetron
Binding Sites
Atoms
2-chloro-(4-methylpiperazine-1-yl)quinoxaline

Cite this

Thompson, A.J. ; Verheij, M.H.P. ; van Muijlwijk-Koezen, Jacqueline E. ; Lummis, Sarah C R ; Leurs, R. ; de Esch, Iwan. / Structure-activity relationships of quinoxaline-based 5-HT3A and 5-HT3AB receptor-selective ligands. In: ChemMedChem. 2013 ; Vol. 8, No. 6. pp. 946-955 .
@article{0c73b97f4120438cb66aeceb9c373790,
title = "Structure-activity relationships of quinoxaline-based 5-HT3A and 5-HT3AB receptor-selective ligands",
abstract = "Until recently, discriminating between homomeric 5‐HT3A and heteromeric 5‐HT3AB receptors was only possible with ligands that bind in the receptor pore. This study describes the first series of ligands that can discriminate between these receptor types at the level of the orthosteric binding site. During a recent fragment screen, 2‐chloro‐3‐(4‐methylpiperazin‐1‐yl)quinoxaline (VUF10166) was identified as a ligand that displays an 83‐fold difference in [3H]granisetron binding affinity between 5‐HT3A and 5‐HT3AB receptors. Fragment hit exploration, initiated from VUF10166 and 3‐(4‐methylpiperazin‐1‐yl)quinoxalin‐2‐ol, resulted in a series of compounds with higher affinity at either 5‐HT3A or 5‐HT3AB receptors. These ligands reveal that a single atom is sufficient to change the selectivity profile of a compound. At the extremes of the new compounds were 2‐amino‐3‐(4‐methylpiperazin‐1‐yl)quinoxaline, which showed 11‐fold selectivity for the 5‐HT3A receptor, and 2‐(4‐methylpiperazin‐1‐yl)quinoxaline, which showed an 8.3‐fold selectivity for the 5‐HT3AB receptor. These compounds represent novel molecular tools for studying 5‐HT3 receptor subtypes and could help elucidate their physiological roles.",
author = "A.J. Thompson and M.H.P. Verheij and {van Muijlwijk-Koezen}, {Jacqueline E.} and Lummis, {Sarah C R} and R. Leurs and {de Esch}, Iwan",
year = "2013",
month = "6",
doi = "10.1002/cmdc.201300032",
language = "English",
volume = "8",
pages = "946--955",
journal = "ChemMedChem",
issn = "1860-7179",
publisher = "John Wiley and Sons Ltd",
number = "6",

}

Structure-activity relationships of quinoxaline-based 5-HT3A and 5-HT3AB receptor-selective ligands. / Thompson, A.J.; Verheij, M.H.P.; van Muijlwijk-Koezen, Jacqueline E.; Lummis, Sarah C R; Leurs, R.; de Esch, Iwan.

In: ChemMedChem, Vol. 8, No. 6, 06.2013, p. 946-955 .

Research output: Contribution to JournalArticleAcademicpeer-review

TY - JOUR

T1 - Structure-activity relationships of quinoxaline-based 5-HT3A and 5-HT3AB receptor-selective ligands

AU - Thompson, A.J.

AU - Verheij, M.H.P.

AU - van Muijlwijk-Koezen, Jacqueline E.

AU - Lummis, Sarah C R

AU - Leurs, R.

AU - de Esch, Iwan

PY - 2013/6

Y1 - 2013/6

N2 - Until recently, discriminating between homomeric 5‐HT3A and heteromeric 5‐HT3AB receptors was only possible with ligands that bind in the receptor pore. This study describes the first series of ligands that can discriminate between these receptor types at the level of the orthosteric binding site. During a recent fragment screen, 2‐chloro‐3‐(4‐methylpiperazin‐1‐yl)quinoxaline (VUF10166) was identified as a ligand that displays an 83‐fold difference in [3H]granisetron binding affinity between 5‐HT3A and 5‐HT3AB receptors. Fragment hit exploration, initiated from VUF10166 and 3‐(4‐methylpiperazin‐1‐yl)quinoxalin‐2‐ol, resulted in a series of compounds with higher affinity at either 5‐HT3A or 5‐HT3AB receptors. These ligands reveal that a single atom is sufficient to change the selectivity profile of a compound. At the extremes of the new compounds were 2‐amino‐3‐(4‐methylpiperazin‐1‐yl)quinoxaline, which showed 11‐fold selectivity for the 5‐HT3A receptor, and 2‐(4‐methylpiperazin‐1‐yl)quinoxaline, which showed an 8.3‐fold selectivity for the 5‐HT3AB receptor. These compounds represent novel molecular tools for studying 5‐HT3 receptor subtypes and could help elucidate their physiological roles.

AB - Until recently, discriminating between homomeric 5‐HT3A and heteromeric 5‐HT3AB receptors was only possible with ligands that bind in the receptor pore. This study describes the first series of ligands that can discriminate between these receptor types at the level of the orthosteric binding site. During a recent fragment screen, 2‐chloro‐3‐(4‐methylpiperazin‐1‐yl)quinoxaline (VUF10166) was identified as a ligand that displays an 83‐fold difference in [3H]granisetron binding affinity between 5‐HT3A and 5‐HT3AB receptors. Fragment hit exploration, initiated from VUF10166 and 3‐(4‐methylpiperazin‐1‐yl)quinoxalin‐2‐ol, resulted in a series of compounds with higher affinity at either 5‐HT3A or 5‐HT3AB receptors. These ligands reveal that a single atom is sufficient to change the selectivity profile of a compound. At the extremes of the new compounds were 2‐amino‐3‐(4‐methylpiperazin‐1‐yl)quinoxaline, which showed 11‐fold selectivity for the 5‐HT3A receptor, and 2‐(4‐methylpiperazin‐1‐yl)quinoxaline, which showed an 8.3‐fold selectivity for the 5‐HT3AB receptor. These compounds represent novel molecular tools for studying 5‐HT3 receptor subtypes and could help elucidate their physiological roles.

U2 - 10.1002/cmdc.201300032

DO - 10.1002/cmdc.201300032

M3 - Article

VL - 8

SP - 946

EP - 955

JO - ChemMedChem

JF - ChemMedChem

SN - 1860-7179

IS - 6

ER -